EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.1.1.158 | Asthma |
3409624 |
Biochemical studies of N-methyltransferase in human and guinea-pig lung: no apparent role in the pathogenesis of asthma. |
causal interaction
ongoing research
unassigned |
3
2
0 |
| 2.1.1.158 | Asthma |
15693910 |
No association of histamine- N-methyltransferase polymorphism with asthma or bronchial hyperresponsiveness in two German pediatric populations. |
unassigned |
0 |
| 2.1.1.158 | Asthma |
20423833 |
[Expression of protein arginine N-methyltransferases in E3 rat models of acute asthma.] |
ongoing research
unassigned |
4
0 |
| 2.1.1.158 | Brachydactyly |
34244600 |
Novel PRMT7 mutation in a rare case of dysmorphism and intellectual disability. |
causal interaction
diagnostic usage
unassigned |
3
1
0 |
| 2.1.1.158 | Breast Neoplasms |
27926873 |
FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. |
unassigned |
0 |
| 2.1.1.158 | Breast Neoplasms |
29964331 |
Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation. |
causal interaction
therapeutic application
unassigned |
2
4
0 |
| 2.1.1.158 | Carcinogenesis |
27179036 |
In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype. |
unassigned |
0 |
| 2.1.1.158 | Carcinogenesis |
27766425 |
Reduced expression of SETD2 and SNX9 proteins in chemically induced mammary tumorigenesis in Wistar rats: a prognostic histological and proteomic study. |
causal interaction
diagnostic usage
unassigned |
2
2
0 |
| 2.1.1.158 | Carcinogenesis |
31734267 |
Molecular signature of interleukin-22 in colon carcinoma cells and organoid models. |
ongoing research
unassigned |
3
0 |
| 2.1.1.158 | Carcinogenesis |
33240432 |
Downregulation of histone-lysine N-methyltransferase EZH2 inhibits cell viability and enhances chemosensitivity in lung cancer cells. |
causal interaction
ongoing research
unassigned |
1
1
0 |
